Drug giant AstraZeneca instructed its sales representatives to tell doctors that there was no link between its antipsychotic drug Seroquel and an increased risk of diabetes, even though studies conducted by the company had already shown otherwise, according to documents uncovered as part of a lawsuit.
AstraZeneca is the target of more than 9,000 lawsuits alleging that the company concealed information about the diabetes risks posed by Seroquel and that it illegally marketed the drug for "off label" uses not approved by the FDA.
Seroquel is approved only for the treatment of schizophrenia and bipolar disorder, but is also prescribed off-label to treat anxiety and insomnia.
Read more...
No comments:
Post a Comment
Thanks for your comment it is much appreciated.